corticosteroids - versus control - for COVID 19 all comers pdf   xlsx method abbreviations

Outcome Relative effect 95%CI LoD Trt. better when I2 k (RCT/OBS) Bayesian probability Overall ROB Publication bias Degree of certainty Endpoint importance Published MA

efficacy endpoints 00

deaths 0.98 [0.93, 1.02]< 10%1 study (1/-)83.9 %some concernnot evaluable moderatecrucial-
clinical deterioration 0.35 [0.06, 2.12]< 151%2 studies (2/-)87.1 %some concernnot evaluable moderateimportant-
clinical improvement (14-day) 1.33 [0.57, 3.11]> 10%1 study (1/-)74.2 %some concernnot evaluable moderateimportant-
ICU admission 1.00 [0.13, 7.45]< 10%1 study (1/-)50.0 %some concernnot evaluable moderatenon important-

LoD: level of demonstration ( demonstrated, suggested, inconclusive, safety concerns);
Bayesian probability: Bayesian posterior probability of treatment effect (computed with a noninformative prior); ROB: risk of bias; k: number of studies; published MA: number of published meta-analysis on the same topic; degree of certainty adapted from GRADE. Trt. better when: indicates when the relative treatment effect shows that the studied treatment is better than control.